Removing the Designation of Cancer from Grade Group 1 Disease Will Do More Good than Harm-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Removing the Designation of Cancer from Grade Group 1 Disease Will Do More Good than Harm

Published:2023-04 Issue:4 Volume:83 Page:304-306
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Vickers Andrew J.,Cooperberg Matthew R.,Eggener Scott E.

Funder

Sidney Kimmel Center for Prostate and Urologic Cancers

National Institutes of Health

National Cancer Institute

Prostate Cancer Foundation

Publisher

Elsevier BV

Subject

Urology

Reference16 articles.

1. Prostate adenocarcinoma grade group 1: rationale for retaining a cancer label in the 2022 World Health Organization classification;Netto;Eur Urol,2023

2. The diverse genomic landscape of clinically low-risk prostate cancer;Cooperberg;Eur Urol,2018

3. Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies;Van Neste;Prostate,2016

4. Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy?;Ahmed;Lancet Oncol,2012

5. An exploration of wellbeing in men diagnosed with prostate cancer undergoing active surveillance: a qualitative study;Eymech;Support Care Cancer,2022

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Re: Long-term Prostate Cancer–specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer;European Urology;2024-08

2. Risk of Biochemical Recurrence in Patients With Grade Group 1 Prostate Cancer With Extraprostatic Extension Treated With Radical Prostatectomy;Journal of Urology;2023-12-18

3. Outcomes of Biopsy Grade Group 1 Prostate Cancer Diagnosis in the Danish Population;European Urology Oncology;2023-10

4. Reply to X. Farré et al;JCO Global Oncology;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3